The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSeoul National University Hospital
About this trial
Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.
Eligibility criteria
Qualifiers
Adults 19 years and older
Hospitalized in the surgical/medical intensive care unit of the Seoul National University Hospital
Enteral nutrition
Patients who consented to this study
Disqualifiers
chronic pancreatitis
unresectable pancreatic cancer
History of pancreatectomy
Underlying diseases in which the effect of Exocrine pancreatic enzyme administration is difficult to show
Trial design
Treatments tested in this trial
- Exocrine Pancreatic Enzyme
- Placebo
Treatment groups
170 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov